Topic List : Infectious Disease
Drug blocks several mosquito-borne viruses
A new Stanford study details how to shut off proteins in mammalian cells to keep viruses such as Zika, dengue and West Nile from replicating in them.
High cost of fewer measles vaccinations
A 5 percent drop in childhood measles vaccination levels would cause annual measles cases to triple, according to researchers at Stanford and Baylor.
Preventing HIV among drug users
As more people inject drugs like heroin, the risk of an HIV outbreak from shared needles increases. Stanford researchers examined four methods that could be cost-effective in preventing an outbreak.
Samuel So on ending viral hepatitis
A Stanford liver disease expert and leading anti-hepatitis campaigner recently discussed what it will take to rub out viral hepatitis and why it’s important. Hint: It causes more than 20,000 U.S. deaths annually.
Drug combo effective against dengue, Ebola
To develop a potential antiviral treatment, Stanford researchers adopted an unusual approach: Rather than trying to disable viral enzymes, they targeted proteins the infected individual makes — and the virus needs.
Test could help prevent TB deaths
A Stanford investigator and his colleagues found that a screening test for tuberculosis was a good predictor of whether children infected with the bacteria would become sick.
Clues to why severe dengue affects some
A new study has found a specific immunologic response among people likely to get severe dengue disease. The work could help lead to a screening test for people at risk of getting a serious case of the disease and to targeted vaccines.
Study confirms existence of asymptomatic Ebola
A research team determined that 25 percent of individuals in a Sierra Leone village were infected with the Ebola virus but had no symptoms, suggesting broader transmission of the virus than originally thought.
ITI awards seed grants
Seed grants were awarded to seven faculty teams and individuals, as well as to eight young investigators, for the coming year.
Kim discusses Biohub infectious disease project
The Chan Zuckerberg Biohub will include two major research projects intended to help cure and prevent disease. One, focusing on infectious disease, will be led by biochemist Peter Kim.